ArticleGut2023
Serological responses to three doses of SARS-CoV-2 vaccination in inflammatory bowel disease.
Abstract readLetterComment
In one paragraph
Article in Gut, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.
0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
–field-weighted citation impact
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
11 citing papers in PubMed.
- Article
- Durability of Antibody Responses to SARS-CoV-2 Vaccination over 12 Months in Pediatric Inflammatory Bowel Disease.Vaccines · 2025Article
- Higher and Sustained Cell-Mediated Immune Responses After 3 Doses of mRNA COVID-19 Vaccine in Patients With Inflammatory Bowel Disease on Anti-Tumor Necrosis Factor Therapy.Clinical and translational gastroenterology · 2024Article
- A Practical Update on COVID-19 and Inflammatory Bowel Disease: COVID-19 Disease Risk and Vaccine Safety and Efficacy.Gastroenterology & hepatology · 2024Article
- Immunization of children with inflammatory bowel disease against SARS-CoV-19 infection: A prospective single centre cohort study.Vaccine: X · 2023Article
- The 2023 Impact of Inflammatory Bowel Disease in Canada: COVID-19 and IBD.Journal of the Canadian Association of Gastroenterology · 2023Review
- Humoral Immunity in Immunosuppressed IBD Patients after the Third SARS-CoV-2 Vaccination: A Comparison with Healthy Control Subjects.Vaccines · 2023Article
- COVID-19 vaccination in adults with inflammatory bowel disease.Therapeutic advances in gastroenterology · 2023Review
- Systemic and T cell-associated responses to SARS-CoV-2 immunisation in gut inflammation (STAR SIGN study): effects of biologics on vaccination efficacy of the third dose of mRNA vaccines against SARS-CoV-2.Alimentary pharmacology & therapeutics · 2023Article
- Serological responses to the first four doses of SARS-CoV-2 vaccine in patients with inflammatory bowel disease.The lancet. Gastroenterology & hepatology · 2022Article
- COVID-19 vaccine-induced antibody and T-cell responses in immunosuppressed patients with inflammatory bowel disease after the third vaccine dose (VIP): a multicentre, prospective, case-control study.The lancet. Gastroenterology & hepatology · 2022Article
Corrections and comments
- Comment on
Authors and funding
20 authors.
Joshua QuanInflammatory Bowel Disease Clinic, Department of Medicine, Cumming School of Medicine, University of Calgary, Calgary, Alberta, Canada.
Christopher MaInflammatory Bowel Disease Clinic, Department of Medicine, Cumming School of Medicine, University of Calgary, Calgary, Alberta, Canada.ORCID 0000-0002-4698-9948
Remo PanaccioneInflammatory Bowel Disease Clinic, Department of Medicine, Cumming School of Medicine, University of Calgary, Calgary, Alberta, Canada.
Lindsay HracsInflammatory Bowel Disease Clinic, Department of Medicine, Cumming School of Medicine, University of Calgary, Calgary, Alberta, Canada.
Nastaran SharifiInflammatory Bowel Disease Clinic, Department of Medicine, Cumming School of Medicine, University of Calgary, Calgary, Alberta, Canada.
Michelle HeraufInflammatory Bowel Disease Clinic, Department of Medicine, Cumming School of Medicine, University of Calgary, Calgary, Alberta, Canada.
Ante MakovinovićInflammatory Bowel Disease Clinic, Department of Medicine, Cumming School of Medicine, University of Calgary, Calgary, Alberta, Canada.
Stephanie CowardInflammatory Bowel Disease Clinic, Department of Medicine, Cumming School of Medicine, University of Calgary, Calgary, Alberta, Canada.
Joseph W WindsorInflammatory Bowel Disease Clinic, Department of Medicine, Cumming School of Medicine, University of Calgary, Calgary, Alberta, Canada.
Léa CaplanInflammatory Bowel Disease Clinic, Department of Medicine, Cumming School of Medicine, University of Calgary, Calgary, Alberta, Canada.
Richard J M IngramInflammatory Bowel Disease Clinic, Department of Medicine, Cumming School of Medicine, University of Calgary, Calgary, Alberta, Canada.
Jamil N KanjiAlberta Precision Laboratories, Public Health Laboratory, Calgary, Alberta, Canada.
Graham TipplesAlberta Precision Laboratories, Public Health Laboratory, Calgary, Alberta, Canada.
Jessalyn K HolodinskyDepartment of Clinical Neuroscience, Cumming School of Medicine, University of Calgary, Calgary, Alberta, Canada.
Charles N BernsteinUniversity of Manitoba IBD Clinical and Research Centre and Department of Medicine, Max Rady College of Medicine, University of Manitoba, Winnipeg, Manitoba, Canada.ORCID 0000-0001-8041-3574
Douglas J MahoneyDepartment of Microbiology, Immunology and Infectious Disease, University of Calgary, Calgary, Alberta, Canada.
Sasha BernatskyDivisions of Rheumatology and Clinical Epidemiology, Department of Medicine, McGill University Health Centre, Montreal, Quebec, Canada.
Eric I BenchimolICES, Toronto, Ontario, Canada.ORCID 0000-0001-8855-3598
Gilaad G KaplanInflammatory Bowel Disease Clinic, Department of Medicine, Cumming School of Medicine, University of Calgary, Calgary, Alberta, Canada ggkaplan@ucalgary.ca.ORCID 0000-0003-2719-0556
STOP COVID-19 in IBD Research Group
Funding
CIHR VR5-172684
Abstract
PubMed holds no abstract for this paper.
Indexed as
COVID-19Inflammatory Bowel DiseasesCOVID-19 VaccinesHumansSARS-CoV-2VaccinationCOVID-19 VaccinesCOVID-19CROHN'S DISEASEULCERATIVE COLITIS
Identifiers
What OpenQuestion holds
Textmetadata
LicenceCC BY-NC
Read underepoch 390
Registered trials
None linked
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.